Professor, Medicine, Case Western Reserve University School of Medicine
Cardiology
Dr. Bruce L. Wilkoff, MD
|
|
Give Review
Bruce L. Wilkoff, MD is an expert in the field of Cardiology. He studied medicine at The Ohio State University College of Medicine. He over the years received 8 awards: "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Fellow (FACC)", "Fellow (FHRS)", "Fellow (FAHA)", "Phi Eta Sigma", "Beta Mu Epsilon" and "Tau Beta Pi". Dr. Bruce L. Wilkoff is also a published MD. He has 101 publication published. The most recent publication is: Considerations for cardiac device lead extraction. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Advances in implantable cardioverter defibrillator therapy.
- The biostability of cardiac lead insulation materials as assessed from long-term human implants.
- Comparison of left ventricular torsion and strain with biventricular pacing in patients with underlying right bundle branch block versus those with left bundle branch ...
- Noninvasive Mapping of Electrical Dyssynchrony in Heart Failure and Cardiac Resynchronization Therapy.
- Long-term outcomes in patients with ambulatory new york Heart association class III and IV Heart failure undergoing cardiac resynchronization therapy.
- Tricuspid Regurgitation and Implantable Devices.
- Reverse ventricular remodeling and long-term survival in patients undergoing cardiac resynchronization with surgically versus percutaneously placed left ventricular pa...
- Using a novel wireless system in monitoring patients after the Atrial fibrillation ablation procedure: The iTransmit study.
- Standardized MR Terminology and Reporting of Implants and Devices as Recommended by the American College of Radiology Subcommittee on MR Safety.
- Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infecti...
- Cardiac implantable electronic device infections: facts, current practice, and the unanswered questions.
- The Impact of Changing Antiseptic Skin Preparation Agent used for Cardiac Implantable Electronic Device (CIED) Procedures on the Risk of Infection.
- The epidemic of inadequate biventricular pacing in patients with persistent or permanent Atrial fibrillation and its association with mortality.
- Clinical predictors of adverse patient outcomes in an experience of more than 5000 Chronic endovascular pacemaker and defibrillator lead extractions.
- Shock Avoidance and the Newer Tachycardia Therapy Algorithms.
- Conductor externalization of the Biotronik Kentrox internal cardioverter defibrillator lead: The tip of another iceberg?
- Multicenter experience with extraction of the Riata/Riata ST ICD lead.
- Incidence, management, and outcomes of the arteriovenous fistula complicating transvenous lead extraction.
- Low cardiac output associated with ventricular tachyArrhythmias in continuous-flow LVAD recipients with a concomitant ICD (LoCo VT Study).
- Outcomes after endocarditis or device infection in patients with left ventricular epicardial leads versus Coronary sinus leads.
- Survival in Octogenarians Undergoing Cardiac Resynchronization Therapy Compared to the General Population.
- A clinical prediction rule to identify patients at heightened risk for early demise following cardiac resynchronization therapy.
- Survival of patients with biventricular devices after device infection, extraction, and reimplantation.
- Durability of Survival Effect of Cardiac Resynchronization Therapy by Level of Left Ventricular Functional Improvement: Fate of "Non-Responders"
- Does CHA2DS2-VASc Improve Stroke Risk Stratification in Postmenopausal Women with Atrial Fibrillation?
- Short and Long Term Electrical Performance of the 5086 MRI Pacing Lead.
- Safe MRI Scanning of Patients with Cardiac Rhythm Devices: A Role forComputer Modeling.
- Transvenous extraction of implantable cardioverter-defibrillator leads under advisory-A comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-...
- Understanding lead dysfunction: Managing lead Failure grief.
- Myocardial scar burden predicts survival benefit with implantable cardioverter defibrillator implantation in patients with severe ischaemic Cardiomyopathy: influence o...
- Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry.
- Management of cardiac implantable electronic device infections: the challenges of understanding the scope of the problem and its associated mortality.
- Clinical Experience and Procedural Outcomes Associated with the DF4 Implantable Cardioverter Defibrillator System: The SJ4 Postapproval Study.
- The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011.
- ACR guidance document on MR safe practices: 2013.
- Superior vena cava defibrillator coils make transvenous lead extraction more challenging and riskier.
- Role of CMR Imaging in Risk Stratification for Sudden Cardiac Death.
- QRS narrowing is associated with reverse remodeling in patients with Chronic right ventricular pacing upgraded to cardiac resynchronization therapy.
- Active fixation mechanism complicates Coronary sinus lead extraction and limits subsequent reimplantation targets.
- Remote monitoring of cardiovascular devices: a time and activity analysis.
- Safety of repetitive nerve stimulation in patients with cardiac implantable electronic devices.
- Cardiac Venous Left Ventricular Lead Removal and Reimplantation Following Device Infection: A Large Single-Center Experience.
- Every life counts.
- Implantable cardioverter-defibrillator FDA safety advisories: Impact on patient mortality and morbidity.
- Differential Echocardiographic Response to Cardiac Resynchronization Therapy and Clinical Outcomes According to QRS Morphology and QRS Duration.
- QRS Prolongation Induced by Cardiac Resynchronization Therapy Correlates with Deterioration in Left Ventricular Function.
- Letter to Editor Response: Percutaneous extraction of stented device leads.
- Collaboration and engagement drive Heart Rhythm Society progress.
- Percutaneous extraction of stented device leads.
- Impact of Mitral Regurgitation on Reverse Remodeling and Outcome in Patients Undergoing Cardiac Resynchronization Therapy.
- The impact of left ventricular size on response to cardiac resynchronization therapy.
- Predictors of response to cardiac resynchronization therapy in patients with a non-left bundle branch block morphology.
- Continuous hemodynamic monitoring in patients with mild to moderate Heart failure: results of The Reducing Decompensation Events Utilizing Intracardiac Pressures in Pa...
- The Impact of AF with Rapid Ventricular Rates and Device Programming on Shocks in 106,513 ICD and CRT-D Patients.
- CRT or CRT-D devices? The case for 'high energy' devices.
- Extraction of Implantable Cardiac Electronic Devices.
- Guidance for the Heart rhythm society pertaining to interactions with industry endorsed by the Heart rhythm society on april 26, 2011.
- Prognostic Significance of Atrial Arrhythmias in a Primary Prevention ICD Population.
- Chest radiography is a poor predictor of left ventricular lead position in patients undergoing cardiac resynchronization therapy: comparison with multidetector compute...
- ICDs: Evidence, guidelines and glitches.
- QRS Fragmentation Is Not Associated with Poor Response to Cardiac Resynchronization Therapy.
- Pivotal trials of cardiac resynchronization therapy: evolution to therapy in mild Heart failure.
- Design and rationale of the assessment of proper physiologic response with rate adaptive pacing driven by minute ventilation or accelerometer (APPROPRIATE) trial.
- The QRS Narrowing Index Predicts Reverse Left Ventricular Remodeling Following Cardiac Resynchronization Therapy.
- Infections associated with cardiac implantable electronic devices are misunderstood.
- Long-term outcomes and clinical predictors for pacemaker-requiring bradyArrhythmias after cardiac transplantation: analysis of the UNOS/OPTN cardiac transplant database.
- Fibrotic tissue growth into the extendable lobes of an active fixation Coronary sinus lead can complicate extraction.
- A Heart Rhythm Society Electrophysiology Workforce study: current survey analysis of physician workforce trends.
- Cardiac implantable electronic device infections: presentation, management, and patient outcomes.
- Effectiveness of implantable cardioverter-defibrillator lead coil treatments in facilitating ease of extraction.
- Initial experience with the Evolution mechanical dilator sheath for lead extraction: safety and efficacy.
- Insights from internet-based remote intrathoracic impedance monitoring as part of a Heart failure disease management program.
- Characterization of super-response to cardiac resynchronization therapy.
- Cardiac resynchronization therapy in non-left bundle branch block morphologies.
- Long-term reverse remodeling with cardiac resynchronization therapy: results of extended echocardiographic follow-up.
- Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator.
- Differences in effects of electrical therapy type for ventricular Arrhythmias on mortality in implantable cardioverter-defibrillator patients.
- Usefulness of cardiac resynchronization therapy in patients with Adriamycin-induced Cardiomyopathy.
- Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions.
- Long-term outcomes and clinical predictors for pacing after cardiac transplantation.
- Transiliac ICD implantation: deFibrillation vector flexibility produces consistent success.
- Insights from a cardiac resynchronization optimization clinic as part of a Heart failure disease management program.
- The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial.
- Persistent hemodynamic benefits of cardiac resynchronization therapy with disease progression in advanced Heart failure.
- The impact of Myocardial viability on the clinical outcome of cardiac resynchronization therapy.
- Mortality of Heart failure patients after cardiac resynchronization therapy: identification of predictors.
- The magnitude of reverse remodelling irrespective of aetiology predicts outcome of Heart failure patients treated with cardiac resynchronization therapy.
- Pacemaker and ICD leads: strategies for long-term management.
- Remote cardiac monitoring in patients with Heart failure.
- Prognostic value of electrocardiographic measurements before and after cardiac resynchronization device implantation in patients with Heart failure due to ischemic or ...
- How to treat and identify device infections.
- Lead Failures: dealing with even less perfect.
- Interventional electrophysiology and cardiac resynchronization therapy: delivering electrical therapies for Heart failure.
- Group purchasing organizations: optimizing cardiac device selection, therapy delivery, and fiscal responsibility.
- Dynamic obstruction to Coronary sinus access: the Thebesian valve.
- Usefulness of atrioventricular delay optimization using Doppler assessment of Mitral inflow in patients undergoing cardiac resynchronization therapy.
- Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy.
- Pacemaker and ICD malfunction--an incomplete picture.
- Complications of pacemakers and defibrillators in the elderly.
- Considerations for cardiac device lead extraction.
Schools
Ohio State University College Of Medicine and Public Health
University Hosps Cleveland
Ohio State University
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
- Fellow (FHRS)
- Fellow (FAHA)
- Phi Eta Sigma
- Beta Mu Epsilon
- Tau Beta Pi
Education
-
Ohio State University Hospital -
Case Western Reserve University - University Hospitals -
The Ohio State University College of Medicine
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1982640223 | |
| NPPES Provider LastName | WILKOFF | |
| NPPES Provider FirstName | BRUCE | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Cardiac Electrophysiology | |
| Total Claim Count | 313.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982640223 |
| Last Name Of The Provider | WILKOFF |
| First Name Of The Provider | BRUCE |
| View All |
Similar Doctors
|
|
Dr. Nael Hawwa, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Shyam Bhakta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amar Krishnaswamy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benico Barzilai, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Tom A. Lassar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven E. Nissen, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Milind Y. Desai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Curtis M. Rimmerman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fareed Moses S. Collado, MD |
|
|
Dr. Nishtha Sodhi, MD |